The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy

OBJECTIVE: To determine the combination of fasting blood glucose (FBG) with squamous cell carcinoma antigen (SCCA) assessments in the prediction of tumor responses to chemotherapy and pretreatment prognostication among patients receiving neoadjuvant chemotherapy (NACT) for locally advanced cervical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Miao‐Fang, Guan, Mei‐Mei, Liu, Chang‐Hao, Wu, Jie‐Ying, Rao, Qun‐Xian, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718550/
https://www.ncbi.nlm.nih.gov/pubmed/31310455
http://dx.doi.org/10.1002/cam4.2414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718550/
https://www.ncbi.nlm.nih.gov/pubmed/31310455
http://dx.doi.org/10.1002/cam4.2414

Ejemplares similares